Bone marrow examination
The Efficacy and Safety of the Combination of Elbasvir/Grazoprevir In the Treatment of Chronic Hepatitis C Virus Infection: A Systematic Review of Clinical Trials
6
Secondary Acute Myeloid Leukemia in a One-Year-Old Girl Diagnosed with JAK2-V617F Mutation Positive Myeloproliferative Neoplasm
5
A Case of Parvovirus-Related Haemophagocytic Lymphohistiocytosis in a Patient with HbH Disease
5
A prospective clinico‑hematological study in 100 cases of Pancytopenia in a tertiary care teaching hospital
8
Diagnostic Utility of Bone Marrow Aspiration and Bone Marrow Biopsy in Hematological Practice
5
Experíence and Reason Briefly Recorded
5
Plasma Cell Leukemia: An experience from a Tertiary Hospital
5
Non-purulent pharyngitis: adult still’s disease
5
Original Research Article Serum lactate dehydrogenase in diagnosis of megaloblastic anaemia- An observational study in Central India
8
Prevalence of multiple myeloma and its complication in a tertiary medical college at Calicut district, India
5
Original Article Two reports of juvenile myelomonocytic leukemia and its literature review
7
A Correlative Study on Bone Marrow Angiogenesis with Bone Marrow Fibrosis and Splenomegaly.
119
Clinico-hematological study in pancytopenia patients presenting to tertiary care hospital
113
Results: In our study of 100 patients with acute leukemia, 70 had AML, 27 had ALL and 3 remained as unclassified
10
2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma
7
Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
13
RESEARCH ARTICLE Clinical presentation of acute myeloid leukaemia — A decade-long institutional follow-up
6
Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial
12
Autologous bone marrow cell therapy for peripheral arterial disease
10
H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets
13